Institutional oversight of research involving live vertebrate animals in the United States runs through three distinct mechanisms that are frequently conflated: the Public Health Service (PHS) Policy, administered by NIH’s Office of Laboratory Animal Welfare (OLAW), which attaches to PHS-funded work; the Animal Welfare Act (AWA), a federal statute enforced by USDA’s Animal and Plant Health Inspection Service (APHIS), which attaches to a narrower set of covered species regardless of funding source; and Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International accreditation, which is voluntary and international. At the institutional level, all three converge on a single body: the Institutional Animal Care and Use Committee (IACUC). This guide covers how that committee is structured, how it reviews protocols, and where its authority actually comes from — as an oversight framework, not as a procedures manual for working with animals.
Three separate legal bases, one committee
The single fact that causes the most confusion in this area is that an institution can be answerable to two different federal regimes for the same research program, plus a third voluntary one, and each covers a different population of animals for a different reason.
- PHS Policy / OLAW Assurance applies to any live vertebrate animal used in research, research training, or biological testing supported by a PHS agency (principally NIH, also CDC, FDA, and others). There is no species carve-out: purpose-bred mice and rats, which the AWA excludes, are fully covered. An institution accepting PHS funding must hold an approved Animal Welfare Assurance on file with OLAW and must base its program on the Guide for the Care and Use of Laboratory Animals (National Research Council, 8th edition).
- Animal Welfare Act / USDA registration applies to a defined statutory list of species — dogs, cats, non-human primates, guinea pigs, hamsters, rabbits, and other warm-blooded animals, per 7 U.S.C. 2132(g) — regardless of funding source. Critically, the statute excludes rats of the genus Rattus and mice of the genus Mus bred for research use, birds bred for research use, horses not used in research, and farm animals used for food/fiber/agricultural production. That exclusion (administrative USDA practice since the 1970s, codified into the statutory definition by the 2002 Farm Bill) is the single fact people most often get wrong: it means an all-mouse research program can be entirely outside AWA/USDA jurisdiction while still being fully subject to IACUC review under PHS Policy if it receives PHS funding. AWA-covered facilities register with USDA/APHIS and are subject to unannounced on-site inspection.
- AAALAC International accreditation is voluntary and held by roughly 1,000 institutions worldwide. It is not a legal requirement under either PHS Policy or the AWA, but OLAW accepts current AAALAC accreditation as strong evidence of an adequate program when negotiating an Assurance, and many institutions pursue it as a single external benchmark that spans both regulatory tracks. AAALAC uses the Guide for the Care and Use of Laboratory Animals as its primary accreditation standard and conducts triennial site visits by volunteer ad hoc consultants.
See the full side-by-side comparison: AAALAC vs. IACUC.
The three frameworks compared
| PHS Policy / OLAW Assurance | Animal Welfare Act / USDA registration | AAALAC accreditation | |
|---|---|---|---|
| Legal status | Funding-agency policy (condition of PHS award), not a standalone statute | Federal statute, 7 U.S.C. 2131-2159, implemented at 9 CFR Ch. I Subch. A | Voluntary, private accreditation — no legal force |
| Administered / enforced by | NIH Office of Laboratory Animal Welfare (OLAW) | USDA APHIS Animal Care, via unannounced inspection | AAALAC Council on Accreditation, via triennial site visit |
| Species covered | All live vertebrate animals, no exclusions | Defined species list; excludes purpose-bred rats, mice, and birds, and most farm animals | All species covered by the institution’s animal care and use program |
| Trigger | PHS/NIH (or other PHS agency) funding | Any covered-species research, teaching, testing, or exhibition, regardless of funding | Institutional choice to seek and maintain accreditation |
| Core standard applied | Guide for the Care and Use of Laboratory Animals, 8th ed. | Animal Welfare Regulations, 9 CFR Parts 1-3 | Guide for the Care and Use of Laboratory Animals, 8th ed. (primary standard) |
| Consequence of noncompliance | Award suspension/termination, OLAW restriction on the Assurance | USDA citations, fines, license/registration action | Loss of accreditation (reputational, not regulatory) |
Most research-intensive institutions operate under all three at once: a PHS Assurance because they hold NIH funding, USDA registration because their program also includes AWA-covered species, and AAALAC accreditation as a voluntary program-quality benchmark that satisfies both regulators’ expectations simultaneously. In practice, many AAALAC-accredited institutions apply Guide-based standards to all vertebrate work — AWA-excluded or not — as a matter of institutional policy, which is why the species-exclusion distinction can look academic locally even though it is legally real and matters for institutions that are not AAALAC-accredited or that lack PHS funding for a given project.
IACUC composition requirements
The IACUC’s membership rules come from both frameworks and are largely aligned. Under AWA regulations (9 CFR 2.31) and PHS Policy, a research facility’s CEO or Institutional Official must appoint a committee of at least five voting members (PHS Policy) or at least three (the AWA’s floor, though PHS-funded institutions must meet PHS Policy’s higher requirement) that includes, at minimum:
- A doctor of veterinary medicine with training or experience in laboratory animal science and delegated program authority — the Attending Veterinarian. This member must be a voting participant, not merely a consultant, and holds independent authority to intervene on animal welfare grounds (order treatment, require anesthesia/analgesia, or suspend a procedure) separate from the committee’s own suspension authority.
- A practicing scientist experienced in animal research.
- A member whose primary concerns are in a nonscientific area (e.g., an ethicist, lawyer, or member of the clergy).
- At least one member who is unaffiliated with the institution in any way other than as an IACUC member — not a current employee, not a member of an employee’s immediate family. This member is meant to represent general community interests in the humane care and use of animals and is a required, non-waivable seat under both frameworks.
No member may hold more than one of these designated roles for voting purposes in a way that eliminates a required category, and institutions with multiple campuses or a very large protocol volume commonly run a larger committee than the regulatory floor.
Protocol review pathways
Every proposed use of a live vertebrate animal — research, testing, or teaching — requires IACUC review and approval before work begins, regardless of funding source, and continuing approval (typically annual) throughout the project. There are two review pathways.
| Full Committee Review (FCR) | Designated Member Review (DMR) | |
|---|---|---|
| How it works | The complete protocol is discussed at a convened meeting of a quorum of voting members; approval requires a majority vote of a quorum present | The protocol is circulated to all members with an opportunity to call for full committee review within a set period (typically 5 business days); if no member calls for FCR, one or more designated members (never a majority acting alone, and never a single member who disapproves) review and can approve, require modification, or refer to FCR |
| Who can trigger it | Default pathway for novel or higher-risk protocols, and any protocol a member requests full review for | Any single voting member can block DMR and force the protocol to full committee at any time — DMR is not available for protocols where a member has exercised that right |
| Approval authority | No committee member may approve a protocol they were involved in designing or that presents a conflict of interest; that member may provide information but must be absent from the vote | A designated reviewer cannot disapprove a protocol unilaterally — disapproval requires the full committee, with the PI given the opportunity to respond in writing or in person |
| Typical use | New protocols involving significant pain/distress, novel procedures, or at institutional discretion | Minor amendments, straightforward renewals, and routine protocols at many institutions, where local policy permits it |
Both pathways derive from the same regulatory source (9 CFR 2.31(c) and PHS Policy IV.C.2-3) and produce equally valid IACUC approval — DMR is not a lesser form of review, it is a permitted alternate procedure with its own safeguards, principally the single-member veto that forces any protocol to full committee on request.
The three Rs and the required search for alternatives
Every protocol must justify the number of animals proposed and address Replacement, Reduction, and Refinement — the 3Rs framework. For any procedure that may cause more than momentary or slight pain or distress, both the AWA (9 CFR 2.31(d)(1)(ii)) and PHS Policy require the investigator to have considered alternatives to painful or distressful procedures and to provide written assurance, supported by a documented literature or database search, that the proposed activity does not unnecessarily duplicate previous experiments. A search alone is not sufficient: it must be current (typically within roughly the prior year at time of submission), must use at least one database appropriate to the topic (commonly including AWIC’s own literature-search resources), and must document the sources, dates, and search terms used, not just a conclusion that no alternative was found.
USDA pain and distress categories, including Category E
For AWA-covered species, every approved procedure on the annual USDA report is classified into one of the following categories:
- Category B — animals held for breeding, conditioning, or holding, not yet used in an actual research procedure.
- Category C — procedures that involve no more than momentary or slight pain or distress, and no appropriate anesthetic, analgesic, or tranquilizing drug is required (e.g., routine injections, blood draws).
- Category D — procedures involving accompanying pain or distress for which appropriate anesthetic, analgesic, or tranquilizing drugs are used.
- Category E — procedures involving accompanying pain or distress for which the use of appropriate anesthetic, analgesic, or tranquilizing drugs would adversely affect the procedures, results, or interpretation, so pain-relieving drugs are withheld. Category E requires a separate, specific written scientific justification (not merely that the drugs were inconvenient) and is the category USDA and institutional programs scrutinize most closely; some institutions route any Category E protocol to full committee review as a matter of local policy even where DMR would otherwise be permitted.
PHS Policy uses an analogous pain/distress framework (Categories C and D, referencing USDA’s scheme by cross-reference) rather than a separately codified category system, since PHS-funded work at AWA-registered facilities is reported on the same USDA annual report regardless of species-exclusion status.
Submitting a protocol: the practical process
- Draft the protocol using the institution’s IACUC protocol form, addressing every element the committee is required to evaluate (see the checklist below).
- Complete required training for all listed personnel and enroll in the institution’s occupational health program before the protocol can be approved — see IACUC training requirements and the occupational health program guide for what this actually involves.
- Route for review — the IACUC office assigns the protocol to DMR or FCR per local policy and the protocol’s risk profile.
- Respond to committee stipulations. Most protocols are approved with required modifications (“approved pending stipulations”) rather than approved outright on first submission; the PI addresses each stipulation in writing before final approval issues.
- Receive approval, generally valid for up to three years under PHS Policy with mandatory annual continuing-review checkpoints (institutional practice varies on whether the annual checkpoint is a full re-review or an update filing), after which a full triennial re-review and re-approval is required to continue the work.
- Amend as needed. Any change to personnel, procedures, species, numbers, or pain/distress category requires a written amendment reviewed and approved by the IACUC (via DMR or FCR depending on the scope of the change) before the change is implemented — work may not proceed under an amendment that hasn’t been approved yet, even if the underlying protocol is active.
Protocol-contents checklist
A complete IACUC protocol submission typically documents:
- Scientific rationale and objectives, written for a committee that includes non-scientist members
- Species, strain, source, and number of animals, with a statistical or experience-based justification for the number requested
- 3Rs discussion: replacement consideration, reduction rationale, refinement measures, and the required alternatives-search documentation for any procedure above momentary/slight pain or distress
- Detailed description of all procedures, including frequency, duration, and personnel performing each
- Anesthesia, analgesia, and/or tranquilization plan, or the specific scientific justification if withholding pain relief (Category E)
- Housing, husbandry, and any non-standard environmental or enrichment considerations
- Humane endpoints and criteria for early removal or euthanasia, and the euthanasia method with reference to current AVMA guidelines
- Personnel roster with documented training and occupational-health enrollment status for each individual
- Hazard information (biological, chemical, radiological) requiring IBC or other institutional co-review
- Funding source(s) — needed to determine whether PHS Policy attaches independent of AWA species coverage, and, for NIH applications, to align the protocol with the application’s Vertebrate Animals Section
Aligning the IACUC protocol with the NIH Vertebrate Animals Section
For NIH-funded work, the grant application itself contains a required narrative attachment, the Vertebrate Animals Section (VAS), covering five elements: description of procedures and animal numbers/species, justification for species and numbers, adequacy of veterinary care, minimization of pain and distress, and the euthanasia method (with justification if it deviates from AVMA guidelines). NIH Scientific Review Groups evaluate the VAS as part of scientific and technical merit review at the time of application — before any IACUC protocol necessarily exists in its final approved form. This creates a real compliance point that is easy to miss: the VAS and the IACUC-approved protocol are two separate documents produced on two separate timelines, evaluated by two separate bodies, and NIH will not release funds until IACUC approval is verified and an active PHS Assurance is confirmed, regardless of how the VAS scored. An institution should reconcile the two documents — species, numbers, procedures, and pain/distress handling described in the VAS should match what the IACUC actually approves — before award activation, not discover a mismatch during a post-award audit or a just-in-time funding request. A VAS that describes a materially different protocol than the one IACUC-approved is a common, avoidable audit finding.
Semiannual facility inspections and program review
The IACUC must review the institution’s entire animal care and use program and inspect all animal facilities at least once every six months (PHS Policy IV.B.1-2; 9 CFR 2.31(c)(2)-(3)), using the Guide for the Care and Use of Laboratory Animals as the evaluation standard. The committee produces a written report to the Institutional Official classifying any deficiencies as significant (a threat, or possible threat, to animal health or safety) or minor, each with a correction plan and schedule, noting any minority views among members, and signed by a majority of the committee. See IACUC semiannual program review and facility inspection for the full mechanics of what this report must contain and when it goes to OLAW.
Post-approval monitoring
Approval is not the end of IACUC involvement. Most institutions run a post-approval monitoring (PAM) function — distinct from the semiannual program-level review above — that checks individual active protocols against what was actually approved: verifying personnel match the approved roster, procedures match the approved description, and pain/distress management is being followed as written. PAM findings, along with any reportable adverse events, feed into the IACUC’s ongoing oversight and, where serious or continuing noncompliance is found, into the reporting obligations that run to OLAW and, for AWA-covered species, to USDA. See IACUC post-approval monitoring vs. semiannual program review for how these two mechanisms differ, and IACUC adverse event and unanticipated outcome reporting for the escalation pathway.
How this compares to human-subjects and biosafety oversight
Research programs frequently need more than one of these committees for the same overall project — a study using animal models to develop a technique that will later move to human trials, or animal work involving recombinant DNA, needs each committee’s approval independently; none substitutes for another. See IRB vs. IACUC for how animal-research oversight differs from human-subjects review, and IACUC vs. IBC for how it differs from biosafety oversight of recombinant/synthetic nucleic acid and other biohazard work — relevant background also in the DURC, select agents, and biosafety oversight guide for programs where both committees’ jurisdiction can overlap on the same protocol.
Frequently asked questions
Does every institution need an IACUC?
Any institution conducting animal research, teaching, or testing with AWA-covered species, or receiving PHS funding for work involving any live vertebrate animal, must convene an IACUC. An institution with no covered-species work and no PHS funding involving vertebrates has no federal trigger requiring one, though many still maintain a committee as a matter of policy, particularly if they anticipate future federal funding or accreditation.
Is IACUC approval required for animals excluded from the Animal Welfare Act, like laboratory mice?
Yes, if the work is PHS-funded (or the institution has voluntarily extended Guide-based oversight to all vertebrate work, which most AAALAC-accredited institutions do). The AWA’s species exclusion affects USDA’s inspection jurisdiction and the annual USDA report, not whether PHS Policy or institutional policy requires IACUC review.
Can a protocol be approved by a single committee member?
No. Designated Member Review allows one or more designated members to approve, but a single member reviewing under DMR cannot disapprove a protocol unilaterally, and any voting member can force full committee review by requesting it. Full committee approval always requires a majority vote of a quorum at a convened meeting.
How long does IACUC approval last?
Up to three years under PHS Policy, generally with an annual continuing-review checkpoint in between, after which full re-review and re-approval is required. Any material change during that period requires an approved amendment first — the three-year clock does not permit unreviewed drift from what was originally approved.
What’s the difference between an OLAW Assurance and USDA registration?
An OLAW Assurance is a negotiated agreement between an institution and NIH’s Office of Laboratory Animal Welfare, required to receive or hold PHS funding for vertebrate-animal work; it exists under PHS Policy. USDA registration is a separate, statute-based requirement under the Animal Welfare Act for any facility using AWA-covered species, entirely independent of funding source, and is enforced through USDA/APHIS inspection rather than a funding-agency relationship. An institution can hold one, both, or (if it does covered-species work without federal funding and never accredits) neither AAALAC accreditation, while still needing both an Assurance and USDA registration depending on its actual research population.
